Columbia University Medical Center
NewYork-Presbyterian Hospital The University Hospital of Columbia and Cornell
July 23, 2009

Vanda Pharmaceuticals Inc. won approval in May to sell Fanapt, a schizophrenia drug that had been abandoned by three companies and rejected initially by U.S. regulators.

Read more at Bloomberg">Read more at Bloomberg

 

hora interior